This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bobba, N.
Right arrow Articles by Kaplan, M. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bobba, N.
Right arrow Articles by Kaplan, M. S.
PEDIATRICS Vol. 114 No. 2 August 2004, pp. 543

SUPPLEMENT ARTICLE

EFFICACY OF A SHORT COURSE OF PARENT-INITIATED ORAL PREDNISOLONE FOR VIRAL WHEEZE IN CHILDREN AGED 1 TO 5 YEARS: RANDOMIZED CONTROLLED TRIAL

Naveena Bobba, MD and Michael S. Kaplan, MD

Los Angeles, CA

The first 20% of the full text of this article appears below.

Oommen A, Lambert P, Grigg J. Lancet. 2003;362:1433–1438


   Purpose of the Study.
 
To determine whether a parent-initiated, short course of oral prednisolone treatment for viral wheeze decreased mean 7-day daytime and nighttime lower respiratory symptom scores among children 1 to 5 years of age.


   Study Population.
 
Children 1 to 5 years of age who were admitted for treatment of viral wheeze, which was defined as an acute episode of wheezing that occurred within 2 days of coryzal upper respiratory tract symptoms, were studied.


   Methods.
 
Children were recruited for this double-blind, randomized, placebo-controlled trial from the University Hospitals of Leicester National Health Service Trust Hospital. A pediatrician confirmed the diagnosis . . . [Full Text of this Article]